feed,title,long_url,short_url
Investors,"FDA Approves Biogen, Eisai's Highly Anticipated Alzheimer's Treatment",https://www.investors.com/news/technology/biogen-eisai-under-the-skin-subcutaneous-leqembi-alzheimers-treatment/,
